Stuart Falber > WilmerHale > Boston, United States > Lawyer Profile
WilmerHale Offices
60 STATE STREET
BOSTON, MA 02109
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Stuart Falber
Work Department
Capital Markets Corporate Governance and Disclosure; Cross-Border Transactions; Emerging Company and Venture Capital; Life Sciences; Mergers and Acquisitions
Position
Partner
Co-Chair, Life Sciences Group
Career
Stuart Falber exclusively represents clients in the life sciences area. For 30 years, Mr. Falber has served as counsel for a broad range of life sciences clients, ranging from startup private companies to mature public companies, investment banks and venture capital funds.
Mr. Falber’s practice focuses on corporate and securities law, with an emphasis on private and public company counseling; representation of issuers, investment banks and investors in venture capital transactions, public offerings and other financing transactions; mergers and acquisitions, including public and private company acquisitions and dispositions, asset acquisitions and sales, and public and private company spinoffs; and corporate collaborations and licensing transactions.
Learn more about Mr. Falber’s practice and how he can support your startup on WilmerHaleLaunch.com.
Professional Activities
Mr. Falber is a member of the American Bar Association, the Massachusetts Bar Association and the Boston Bar Association. He previously served as a member of the Boston Bar Association’s 2017 Life Sciences Conference Advisory Committee.
Memberships
Bar Admissions:
Massachusetts
Other Organizations:
American Bar Association
Boston Bar Association
Education
University of Pennsylvania Law School , J.D. (1990)
Tufts University , B.A. (1987)
Lawyer Rankings
United States > Finance > Capital markets: equity offerings
WilmerHale is a major player in pharmaceuticals and life sciences, bringing it a steady flow of capital markets engagements. It represents both issuers and underwriters on a regular basis. While IPOs dropped in 2022, the firm remains active in follow-on offerings, PIPE financings, and at-the-market offerings. Boston’s Stuart Falber is chair of the life sciences group and is active in capital markets offerings, while New York’s Lisa Firenze and Brian Johnson, and Boston partner Cynthia Mazareas are also key figures.
United States > Healthcare > Life sciences
WilmerHale’s primarily Boston-based team advises a range of clients, including diagnostic and medical device corporates, universities and research institutions, and investment banks. Practice co-chair Stuart Falber advises a range of public life science companies on capital markets related matters, while fellow co-chair Lisa Pirozzolo acts in Hatch-Waxman cases and licensing disputes, often appearing before the ITC and the PTAB. Based in New York, David Bassett has an IP litigation focused practice, and often contends with biotech and pharmaceutical patent disputes alongside Robert Gunther, who also handles trade secret cases before arbitration tribunals. Sarah Hogan focuses on the life sciences and digital health industries, and has a great deal of experience in the negotiation of IP licenses and strategic collaborations.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Financial services regulation
- Antitrust > Cartel
- International Trade > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Industry focus > Education
- Industry focus > Native American law
- Intellectual property > Patents: litigation (full coverage)
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > General commercial disputes
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Media, technology and telecoms > Outsourcing
- Dispute resolution > Securities litigation: defense
- Government > State attorneys general
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
- Finance > Capital markets: equity offerings
- M&A/corporate and commercial > Corporate governance
- Government > Government contracts
- Dispute resolution > International arbitration
- Healthcare > Life sciences
- International Trade > Trade remedies and trade policy
- Finance > Capital markets: debt offerings
- International Trade > Customs, export controls and economic sanctions
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: regulatory
- Dispute resolution > Financial services litigation
- Finance > Fintech
- Government > Government relations
- Antitrust > Merger control
- Tax > US taxes: non-contentious
- Finance > Commercial lending
- Dispute resolution > Leading trial lawyers
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Environment > Environment: litigation